Neovasc Inc (NVC):企業の財務・戦略的SWOT分析

◆英語タイトル:Neovasc Inc (NVC) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14461
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neovasc Inc (Neovasc) is a medical device manufacturing company that manufactures, develops, and sells cardiovascular disease products. The company’s products include Neovasc reducer, Neovasc tiara, and Neovasc tissue products. Its Neovasc tiara is a novel transcatheter device that is designed for treating mitral valve disease and mitral regurgitation and a condition that is often severe and can lead to heart failure and death. Neovasc’ Neovasc reducer is used for the treating refractory angina. The company’s reducer procedure uses standard catheter-based techniques. It has its operations in Canada and the US. Neovasc is headquartered in Richmond, British Columbia, Canada.

Neovasc Inc Key Recent Developments

Mar 05,2019: Neovasc Announces Reducer Implant “Live Case” at the CRT Meeting in Washington, DC
Feb 20,2019: Neovasc provides corporate update
Jan 22,2019: Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences
Dec 21,2018: Neovasc receives ISO 13485: 2016 certification
Nov 14,2018: Neovasc announces third quarter 2018 financial results

This comprehensive SWOT profile of Neovasc Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Neovasc Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Neovasc Inc – Key Information
Neovasc Inc – Overview
Neovasc Inc – Key Employees
Neovasc Inc – Key Employee Biographies
Neovasc Inc – Key Operational Heads
Neovasc Inc – Major Products and Services
Neovasc Inc – History
Neovasc Inc – Company Statement
Neovasc Inc – Locations And Subsidiaries
Neovasc Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Neovasc Inc – Business Description
Neovasc Inc – Corporate Strategy
Neovasc Inc – SWOT Analysis
SWOT Analysis – Overview
Neovasc Inc – Strengths
Neovasc Inc – Weaknesses
Neovasc Inc – Opportunities
Neovasc Inc – Threats
Neovasc Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Neovasc Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Neovasc Inc, Key Information
Neovasc Inc, Key Ratios
Neovasc Inc, Share Data
Neovasc Inc, Major Products and Services
Neovasc Inc, History
Neovasc Inc, Key Employees
Neovasc Inc, Key Employee Biographies
Neovasc Inc, Key Operational Heads
Neovasc Inc, Other Locations
Neovasc Inc, Subsidiaries
Neovasc Inc, Key Manufacturing facilities
Neovasc Inc, Key Competitors
Neovasc Inc, SWOT Analysis
Neovasc Inc, Ratios based on current share price
Neovasc Inc, Annual Ratios
Neovasc Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Neovasc Inc, Performance Chart
Neovasc Inc, Ratio Charts

★海外企業調査レポート[Neovasc Inc (NVC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Teradata Corp (TDC):企業の財務・戦略的SWOT分析
    Teradata Corp (TDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Yokohama City University-製薬・医療分野:企業M&A・提携分析
    Summary Yokohama City University (YCU) is an educational university that provides various undergraduate and graduate courses. The institute offers graduate program in various courses such as international management, nanobioscience, medical life science and medicine. It conducts research that contri …
  • AiCuris GmbH & Co KG-製薬・医療分野:企業M&A・提携分析
    Summary AiCuris GmbH & Co KG (AiCuris), a subsidiary of Santo Holding AG is a drug development company that discovers and develops antibacterial and antiviral agents for the treatment of life-threatening infectious diseases. The company’s pipeline products include antiviral and antibacterial agents …
  • Engro Corp Ltd (ENGRO)
    Engro Corp Ltd (ENGRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • ConocoPhillips (COP):石油・ガス:M&Aディール及び事業提携情報
    Summary ConocoPhillips is an independent upstream oil and gas company. The company explore for, produce, transport and market crude oil, bitumen, natural gas, liquefied natural gas (LNG) and natural gas liquids across the world. It has assets across North America, Europe, Asia and Australia. Its ass …
  • Phoenix Petroleum Philippines Inc (PNX):企業の財務・戦略的SWOT分析
    Summary Phoenix Petroleum Philippines Inc (PNX) is an independent oil and gas company that distributes petroleum products and lubricants. The company provides automotive fuels, biodiesel, gasoline and aviation fuels, among others. It offers services such as trading of refined petroleum products and …
  • Noble Group Ltd:企業の戦略・SWOT・財務分析
    Noble Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Noble Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Phylogica Ltd (PYC):企業の財務・戦略的SWOT分析
    Summary Phylogica Ltd (Phylogica) is a biotechnology company that develops intracellular biological therapeutics. The company utilizes proprietary phylomer peptide libraries and screening methodologies to identify unique peptide drug candidates. Its products include libraries and peptides. Phylogica …
  • Fomento de Construcciones y Contratas SA (FCC):企業の財務・戦略的SWOT分析
    Fomento de Construcciones y Contratas SA (FCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Baxter International Inc (BAX):企業の財務・戦略的SWOT分析
    Baxter International Inc (BAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Promentis Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Promentis Pharmaceuticals Inc (Promentis Pharmaceuticals) is a biopharmaceutical company that discovers and develops drugs for the treatment of schizophrenia and other central nervous system disorders. The company also develops therapies for neuropsychiatric disorders. It offers metabotropic …
  • Ipsen SA (IPN):企業の財務・戦略的SWOT分析
    Ipsen SA (IPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Steel Authority Of India Ltd:企業の戦略・SWOT・財務分析
    Steel Authority Of India Ltd - Strategy, SWOT and Corporate Finance Report Summary Steel Authority Of India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Paratek Pharmaceuticals Inc (PRTK):製薬・医療:M&Aディール及び事業提携情報
    Summary Paratek Pharmaceuticals Inc (Paratek) is a biopharmaceutical company that develops and commercializes therapies based on tetracycline chemistry. Omadacycline (antibiotic), the company’s lead product candidate is an aminomethylcycline which acts against gram-negative, gram-positive, and atypi …
  • Basin Electric Power Cooperative
    Basin Electric Power Cooperative - Strategy, SWOT and Corporate Finance Report Summary Basin Electric Power Cooperative - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Unisys Corp (UIS):企業の財務・戦略的SWOT分析
    Unisys Corp (UIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • UEX Corp (UEX):企業の財務・戦略的SWOT分析
    Summary UEX Corp (UEX) is a junior exploration company. The company undertakes the business of acquisition and development of uranium and cobalt deposits in the Athabasca Basin. Its projects portfolio includes Christie Lake project, West Bear project, Horseshoe-Raven project and Shea Creek project. …
  • P/F Atlantic Petroleum (ATLA DKK):企業の財務・戦略的SWOT分析
    Summary P/F Atlantic Petroleum (Atlantic Petroleum) is an oil and gas company that offers development of offshore oil projects. The company's services include exploration, appraisal, development, and production programs. It operates its oil and gas interests in the Norwegian Continental Shelf, the U …
  • Wockhardt Ltd (WOCKPHARMA):製薬・医療:M&Aディール及び事業提携情報
    Summary Wockhardt Ltd (Wockhardt) is a pharmaceutical company that manufactures and markets vaccines, active pharmaceutical ingredients, pharmaceutical and recombinant bio-pharmaceutical formulations. The company's product portfolio caters to various therapeutic areas including orthopedics, dental c …
  • Kimal plc-医療機器分野:企業M&A・提携分析
    Summary Kimal plc (Kimal) is a medical equipment company that develops, manufactures and markets customised procedure packs and vascular access devices. The company’s products include soft tissue biopsy needles, bone marrow biopsy needles, catheter accessories, catheter lock solution, closure device …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆